Glioblastoma  >>  depatuxizumab mafodotin (ABT-414)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
depatuxizumab mafodotin (ABT-414) / AbbVie
NCT03123952: Expanded Access to ABT-414

No Longer Available
N/A
NA
ABT-414
AbbVie
Glioblastoma or Solid Tumors, Epidermal Growth Factor Receptor (EGFR) Diagnosis
 
 

Download Options